Susan Apkon
Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscular Dystrophy, Duchenne | 24 | 2026 | 91 | 5.400 |
Why?
| | Neuromuscular Diseases | 3 | 2025 | 146 | 1.470 |
Why?
| | Osteoporosis | 5 | 2014 | 236 | 1.240 |
Why?
| | Spinal Muscular Atrophies of Childhood | 2 | 2018 | 18 | 0.970 |
Why?
| | Orthopedic Procedures | 2 | 2019 | 243 | 0.950 |
Why?
| | Bone Density | 6 | 2014 | 482 | 0.930 |
Why?
| | Exercise Therapy | 4 | 2019 | 473 | 0.810 |
Why?
| | Myotonic Dystrophy | 1 | 2022 | 10 | 0.710 |
Why?
| | Spinal Dysraphism | 4 | 2025 | 114 | 0.660 |
Why?
| | Morpholinos | 1 | 2019 | 29 | 0.590 |
Why?
| | Child | 33 | 2026 | 22657 | 0.550 |
Why?
| | Disease Management | 3 | 2020 | 647 | 0.530 |
Why?
| | Inpatients | 4 | 2016 | 546 | 0.530 |
Why?
| | Muscular Atrophy, Spinal | 3 | 2025 | 25 | 0.520 |
Why?
| | Musculoskeletal Diseases | 1 | 2018 | 90 | 0.510 |
Why?
| | Muscle Hypotonia | 1 | 2017 | 33 | 0.500 |
Why?
| | Pandemics | 3 | 2020 | 1695 | 0.500 |
Why?
| | Alaska Natives | 2 | 2016 | 149 | 0.490 |
Why?
| | Physical Therapy Modalities | 2 | 2017 | 332 | 0.490 |
Why?
| | Rehabilitation | 1 | 2016 | 20 | 0.460 |
Why?
| | Depression | 2 | 2025 | 1559 | 0.460 |
Why?
| | Myelitis | 1 | 2017 | 107 | 0.460 |
Why?
| | Walking | 2 | 2023 | 545 | 0.450 |
Why?
| | Pediatrics | 2 | 2025 | 1115 | 0.440 |
Why?
| | Occupational Therapy | 1 | 2017 | 111 | 0.440 |
Why?
| | Muscle Spasticity | 2 | 2016 | 63 | 0.420 |
Why?
| | Physical and Rehabilitation Medicine | 2 | 2025 | 30 | 0.400 |
Why?
| | Recovery of Function | 6 | 2019 | 710 | 0.400 |
Why?
| | Primary Health Care | 3 | 2018 | 1734 | 0.400 |
Why?
| | Humans | 57 | 2026 | 144957 | 0.390 |
Why?
| | Lumbosacral Region | 1 | 2012 | 59 | 0.370 |
Why?
| | Cerebral Palsy | 2 | 2016 | 132 | 0.370 |
Why?
| | Healthcare Disparities | 2 | 2016 | 728 | 0.360 |
Why?
| | Fractures, Bone | 2 | 2015 | 415 | 0.360 |
Why?
| | Muscular Dystrophies | 2 | 2012 | 30 | 0.360 |
Why?
| | Neural Tube Defects | 1 | 2012 | 65 | 0.360 |
Why?
| | Terminal Care | 1 | 2016 | 282 | 0.360 |
Why?
| | Parents | 1 | 2021 | 1403 | 0.350 |
Why?
| | Social Determinants of Health | 2 | 2025 | 301 | 0.330 |
Why?
| | Femur | 1 | 2012 | 250 | 0.330 |
Why?
| | Anti-Dyskinesia Agents | 1 | 2010 | 8 | 0.320 |
Why?
| | Botulinum Toxins | 1 | 2010 | 46 | 0.300 |
Why?
| | Critical Illness | 1 | 2016 | 892 | 0.300 |
Why?
| | Neuromuscular Agents | 1 | 2010 | 45 | 0.300 |
Why?
| | Diphosphonates | 2 | 2015 | 68 | 0.290 |
Why?
| | Delivery of Health Care | 2 | 2022 | 947 | 0.280 |
Why?
| | Decision Making | 1 | 2016 | 980 | 0.280 |
Why?
| | Adolescent | 18 | 2026 | 22453 | 0.280 |
Why?
| | Alendronate | 1 | 2008 | 14 | 0.270 |
Why?
| | Oligonucleotides | 2 | 2020 | 151 | 0.270 |
Why?
| | Brain Injuries, Traumatic | 3 | 2021 | 441 | 0.270 |
Why?
| | Meningomyelocele | 1 | 2008 | 61 | 0.270 |
Why?
| | Caregivers | 4 | 2024 | 1049 | 0.260 |
Why?
| | Bone Density Conservation Agents | 1 | 2008 | 81 | 0.260 |
Why?
| | Male | 30 | 2026 | 72406 | 0.250 |
Why?
| | Growth Disorders | 1 | 2026 | 86 | 0.230 |
Why?
| | Rehabilitation Centers | 2 | 2016 | 39 | 0.230 |
Why?
| | Puberty | 1 | 2026 | 140 | 0.220 |
Why?
| | Down Syndrome | 1 | 2012 | 534 | 0.220 |
Why?
| | Certification | 1 | 2025 | 119 | 0.210 |
Why?
| | Prednisone | 2 | 2021 | 221 | 0.200 |
Why?
| | Cross-Sectional Studies | 5 | 2025 | 5872 | 0.200 |
Why?
| | Angelman Syndrome | 1 | 2023 | 10 | 0.200 |
Why?
| | Child, Preschool | 13 | 2025 | 11799 | 0.190 |
Why?
| | Global Health | 2 | 2020 | 401 | 0.190 |
Why?
| | Female | 23 | 2026 | 78376 | 0.190 |
Why?
| | Injections, Spinal | 2 | 2020 | 121 | 0.190 |
Why?
| | Self-Management | 1 | 2025 | 201 | 0.190 |
Why?
| | Retrospective Studies | 13 | 2026 | 17101 | 0.180 |
Why?
| | Health Services Accessibility | 2 | 2024 | 1099 | 0.180 |
Why?
| | Practice Guidelines as Topic | 3 | 2018 | 1563 | 0.180 |
Why?
| | Cone-Beam Computed Tomography | 2 | 2020 | 30 | 0.170 |
Why?
| | Codon, Nonsense | 1 | 2021 | 44 | 0.170 |
Why?
| | Comorbidity | 3 | 2020 | 1660 | 0.170 |
Why?
| | Emergency Medical Services | 2 | 2018 | 696 | 0.170 |
Why?
| | Executive Function | 1 | 2025 | 461 | 0.160 |
Why?
| | Lumbar Vertebrae | 2 | 2016 | 252 | 0.160 |
Why?
| | Medicine | 1 | 2022 | 125 | 0.160 |
Why?
| | Florida | 1 | 2021 | 117 | 0.160 |
Why?
| | Glucocorticoids | 1 | 2025 | 535 | 0.160 |
Why?
| | Absorptiometry, Photon | 2 | 2014 | 276 | 0.160 |
Why?
| | Indians, North American | 2 | 2016 | 647 | 0.160 |
Why?
| | Young Adult | 8 | 2026 | 14126 | 0.160 |
Why?
| | Neoplasms | 1 | 2015 | 2884 | 0.150 |
Why?
| | Education, Special | 1 | 2020 | 23 | 0.150 |
Why?
| | Schools | 2 | 2021 | 453 | 0.150 |
Why?
| | Movement | 1 | 2021 | 294 | 0.140 |
Why?
| | Reproducibility of Results | 3 | 2025 | 3415 | 0.140 |
Why?
| | Intubation, Intratracheal | 1 | 2022 | 320 | 0.140 |
Why?
| | Orthotic Devices | 1 | 2018 | 26 | 0.140 |
Why?
| | Endocrine System | 1 | 2018 | 22 | 0.140 |
Why?
| | Behavioral Symptoms | 1 | 2018 | 43 | 0.130 |
Why?
| | Neuromuscular Junction | 1 | 2018 | 65 | 0.130 |
Why?
| | Severity of Illness Index | 4 | 2021 | 2925 | 0.130 |
Why?
| | Spinal Cord | 1 | 2020 | 382 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
| | Postoperative Care | 1 | 2019 | 288 | 0.130 |
Why?
| | Neurological Rehabilitation | 1 | 2017 | 12 | 0.130 |
Why?
| | Clinical Competence | 1 | 2025 | 1244 | 0.130 |
Why?
| | Rhizotomy | 1 | 2016 | 5 | 0.120 |
Why?
| | Respiratory System | 1 | 2018 | 149 | 0.120 |
Why?
| | Laminectomy | 1 | 2016 | 31 | 0.120 |
Why?
| | Drug Delivery Systems | 1 | 2020 | 381 | 0.120 |
Why?
| | Cardiovascular System | 1 | 2018 | 138 | 0.120 |
Why?
| | Radiography, Interventional | 1 | 2017 | 130 | 0.120 |
Why?
| | Quality of Life | 2 | 2018 | 3192 | 0.110 |
Why?
| | Gastrointestinal Tract | 1 | 2018 | 208 | 0.110 |
Why?
| | Continuity of Patient Care | 1 | 2018 | 292 | 0.110 |
Why?
| | Insurance Coverage | 1 | 2017 | 239 | 0.110 |
Why?
| | Bone and Bones | 1 | 2018 | 315 | 0.110 |
Why?
| | Electric Impedance | 1 | 2015 | 111 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.110 |
Why?
| | Follow-Up Studies | 4 | 2019 | 5417 | 0.110 |
Why?
| | Infant | 6 | 2024 | 10039 | 0.110 |
Why?
| | Adult | 9 | 2025 | 40506 | 0.110 |
Why?
| | Range of Motion, Articular | 1 | 2017 | 424 | 0.110 |
Why?
| | Students | 1 | 2020 | 663 | 0.100 |
Why?
| | Wheelchairs | 2 | 2015 | 15 | 0.100 |
Why?
| | Infant, Newborn | 2 | 2024 | 6434 | 0.100 |
Why?
| | United States | 8 | 2026 | 15988 | 0.100 |
Why?
| | Siblings | 1 | 2014 | 195 | 0.100 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 359 | 0.100 |
Why?
| | Patient Participation | 1 | 2017 | 433 | 0.100 |
Why?
| | Length of Stay | 2 | 2016 | 1337 | 0.090 |
Why?
| | Minority Groups | 1 | 2015 | 282 | 0.090 |
Why?
| | Health Status Disparities | 1 | 2016 | 321 | 0.090 |
Why?
| | Disease Progression | 2 | 2025 | 2852 | 0.090 |
Why?
| | Self Care | 1 | 2015 | 389 | 0.090 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1495 | 0.090 |
Why?
| | Muscle Strength | 1 | 2015 | 330 | 0.090 |
Why?
| | Mental Health Services | 1 | 2018 | 474 | 0.090 |
Why?
| | Hospitals, Pediatric | 1 | 2016 | 557 | 0.090 |
Why?
| | Testosterone | 2 | 2026 | 419 | 0.090 |
Why?
| | Ambulatory Care | 1 | 2017 | 603 | 0.090 |
Why?
| | Internship and Residency | 1 | 2022 | 1257 | 0.090 |
Why?
| | Standard of Care | 1 | 2012 | 80 | 0.090 |
Why?
| | Cohort Studies | 1 | 2022 | 5965 | 0.080 |
Why?
| | Clinical Protocols | 1 | 2012 | 282 | 0.080 |
Why?
| | Risk Factors | 4 | 2015 | 10792 | 0.080 |
Why?
| | Radiography | 1 | 2012 | 845 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2025 | 1416 | 0.080 |
Why?
| | Brain Injuries | 1 | 2015 | 508 | 0.080 |
Why?
| | Vitamin D | 2 | 2015 | 400 | 0.070 |
Why?
| | Thrombophilia | 1 | 2009 | 88 | 0.070 |
Why?
| | Fractures, Spontaneous | 1 | 2008 | 15 | 0.070 |
Why?
| | Calcium, Dietary | 1 | 2008 | 53 | 0.070 |
Why?
| | Neurologic Examination | 1 | 2008 | 131 | 0.070 |
Why?
| | Mobility Limitation | 1 | 2008 | 66 | 0.070 |
Why?
| | Surveys and Questionnaires | 4 | 2026 | 6053 | 0.070 |
Why?
| | Pilot Projects | 2 | 2025 | 1890 | 0.070 |
Why?
| | Sex Factors | 1 | 2014 | 2114 | 0.070 |
Why?
| | Adrenal Cortex Hormones | 2 | 2024 | 479 | 0.060 |
Why?
| | Calcium | 2 | 2015 | 1184 | 0.060 |
Why?
| | Puberty, Delayed | 1 | 2026 | 10 | 0.060 |
Why?
| | Brain Ischemia | 1 | 2009 | 358 | 0.060 |
Why?
| | Human Growth Hormone | 1 | 2026 | 46 | 0.060 |
Why?
| | Torticollis | 1 | 2005 | 17 | 0.060 |
Why?
| | Hospitalization | 1 | 2016 | 2434 | 0.060 |
Why?
| | Hypogonadism | 1 | 2026 | 90 | 0.060 |
Why?
| | United Kingdom | 1 | 2026 | 338 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2015 | 1796 | 0.050 |
Why?
| | Botulinum Toxins, Type A | 1 | 2005 | 58 | 0.050 |
Why?
| | Canada | 1 | 2026 | 428 | 0.050 |
Why?
| | Transition to Adult Care | 1 | 2025 | 96 | 0.050 |
Why?
| | Age Factors | 3 | 2015 | 3335 | 0.050 |
Why?
| | Palliative Care | 1 | 2011 | 1008 | 0.050 |
Why?
| | Risk Assessment | 3 | 2017 | 3676 | 0.050 |
Why?
| | Educational Status | 1 | 2024 | 467 | 0.050 |
Why?
| | Incidence | 3 | 2015 | 2883 | 0.050 |
Why?
| | Neonatal Screening | 1 | 2024 | 178 | 0.040 |
Why?
| | Pregnenediones | 1 | 2021 | 14 | 0.040 |
Why?
| | Medicaid | 2 | 2017 | 462 | 0.040 |
Why?
| | Prednisolone | 1 | 2021 | 66 | 0.040 |
Why?
| | Treatment Adherence and Compliance | 1 | 2021 | 27 | 0.040 |
Why?
| | Telephone | 1 | 2021 | 175 | 0.040 |
Why?
| | Video Recording | 1 | 2021 | 213 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2024 | 1327 | 0.040 |
Why?
| | Gait | 1 | 2023 | 313 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2023 | 842 | 0.040 |
Why?
| | Fluoroscopy | 1 | 2020 | 176 | 0.040 |
Why?
| | Knee Joint | 1 | 2023 | 426 | 0.040 |
Why?
| | Clinical Trials as Topic | 1 | 2024 | 1054 | 0.040 |
Why?
| | Neurosurgical Procedures | 1 | 2020 | 202 | 0.030 |
Why?
| | Biomarkers | 1 | 2009 | 4275 | 0.030 |
Why?
| | Inflammation | 1 | 2009 | 2880 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2024 | 886 | 0.030 |
Why?
| | Nutrition Therapy | 1 | 2018 | 37 | 0.030 |
Why?
| | Internal Fixators | 1 | 2017 | 32 | 0.030 |
Why?
| | Health Personnel | 1 | 2024 | 748 | 0.030 |
Why?
| | Education, Medical, Graduate | 1 | 2022 | 557 | 0.030 |
Why?
| | Phenotype | 1 | 2025 | 3164 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2021 | 1095 | 0.030 |
Why?
| | Washington | 1 | 2017 | 147 | 0.030 |
Why?
| | Appointments and Schedules | 1 | 2017 | 97 | 0.030 |
Why?
| | Iowa | 1 | 2015 | 32 | 0.030 |
Why?
| | Muscle Strength Dynamometer | 1 | 2015 | 23 | 0.030 |
Why?
| | Arizona | 1 | 2015 | 81 | 0.030 |
Why?
| | Georgia | 1 | 2015 | 83 | 0.030 |
Why?
| | Myography | 1 | 2015 | 14 | 0.030 |
Why?
| | Culturally Competent Care | 1 | 2016 | 74 | 0.030 |
Why?
| | New York | 1 | 2015 | 127 | 0.030 |
Why?
| | Efficiency, Organizational | 1 | 2016 | 140 | 0.030 |
Why?
| | Prospective Studies | 2 | 2021 | 7997 | 0.030 |
Why?
| | Linear Models | 1 | 2016 | 854 | 0.030 |
Why?
| | ROC Curve | 1 | 2015 | 615 | 0.020 |
Why?
| | Prognosis | 2 | 2014 | 4293 | 0.020 |
Why?
| | Colorado | 2 | 2015 | 4564 | 0.020 |
Why?
| | Time Factors | 2 | 2015 | 7183 | 0.020 |
Why?
| | Scoliosis | 1 | 2014 | 224 | 0.020 |
Why?
| | Congresses as Topic | 1 | 2012 | 221 | 0.020 |
Why?
| | Cardiomyopathies | 1 | 2014 | 338 | 0.020 |
Why?
| | Databases, Factual | 1 | 2016 | 1486 | 0.020 |
Why?
| | Cognitive Dysfunction | 1 | 2016 | 464 | 0.020 |
Why?
| | Health Status | 1 | 2015 | 836 | 0.020 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2009 | 93 | 0.020 |
Why?
| | Factor VIII | 1 | 2009 | 104 | 0.020 |
Why?
| | Age of Onset | 1 | 2009 | 551 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2009 | 417 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2016 | 11695 | 0.020 |
Why?
| | Cognition | 1 | 2015 | 1269 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2018 | 2313 | 0.020 |
Why?
| | Injections, Intramuscular | 1 | 2005 | 141 | 0.010 |
Why?
| | Middle Aged | 2 | 2020 | 35928 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2005 | 783 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2032 | 0.010 |
Why?
|
|
Apkon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|